Dr. Reddy's Laboratories Limited (DRREDDY) Share Price & AI Investment Analysis

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segmen. Track Dr. Reddy's Laboratories Limited's live NSE:DRREDDY share price ₹1,209.90 (-0.11%), market cap ₹₹1.01T, P/E 30.2. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for DRREDDY — real-time NSE India stock intelligence.